Pres Bush's Medicare discount card plan "will not curb skyrocketing Rx

16 July 2001

US President George W Bush's newly-announced Medicare-EndorsedPrescription Drug Discount Program (see also page 13) is the wrong prescription to curb increasing drug prices for seniors and offers false hope for Medicare recipients, according to the Pharmacy Benefits All Coalition, which represents all aspects of community pharmacy.

State-based prescription discount programs for seniors have been proven not to work, according to Craig Fuller, president and chief executive of the National Association of Chain Drug Stores, which is a member of the coalition, and he added that the same "fallacies" which have been observed with state programs are likely to occur with a national discount card program. "We need a pharmacy benefit that addresses the real problem, the rising cost of prescription drugs," he said.

However, in his announcement of the plan at a Rose Garden ceremony on July 12, Pres Bush had said that the new drug discount program "combines the purchasing clout of millions of seniors to negotiate lower prices than under the current system."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight